The gut virome and regulatory T cell axis in health and systemic disease

Dandan Bi , Shaochen Yu , Mengjie Zhang , Yuting Huang , Ziyue Dou , Beibei Tian , Jian Lu

Microbiome Research Reports ›› 2026, Vol. 5 ›› Issue (2) : 14

PDF
Microbiome Research Reports ›› 2026, Vol. 5 ›› Issue (2) :14 DOI: 10.20517/mrr.2026.20
Review
The gut virome and regulatory T cell axis in health and systemic disease
Author information +
History +
PDF

Abstract

The gut virome, comprising bacteriophages and eukaryotic viruses, represents a complex and dynamic component of the intestinal microbiome whose functional significance has long been underestimated. Emerging evidence highlights the gut virome as a pivotal modulator of the host immune system, particularly in regulating the balance and function of regulatory T cells (Tregs), which are essential for maintaining immune homeostasis. This review distinguishes two mechanistic axes by which the virome influences Tregs: (i) an indirect ‘virome-bacteriome-metabolite-Treg axis’, and (ii) a direct ‘viral pathogen-associated molecular patterns (PAMPs)-pattern recognition receptors (PRRs)-Treg’ signaling axis. This review comprehensively examines the dualistic role of the gut virome in preserving intestinal equilibrium and its involvement in the pathogenesis or amelioration of intestinal inflammatory disorders such as inflammatory bowel disease (IBD). Furthermore, the influence of the gut virome extends beyond the gut, potentially impacting systemic immune-related diseases. By integrating recent advances in metagenomics, viromics, and immunology, we elucidate the molecular mechanisms through which the gut virome orchestrates immune regulation. This synthesis aims to provide a comprehensive understanding of the gut virome as a critical immune regulator and to explore its potential as a biomarker for disease diagnosis and a novel target for therapeutic intervention.

Keywords

Gut virome / bacteriophages / host immunity / regulatory T cells / intestinal inflammation / immune regulation / microbiome

Cite this article

Download citation ▾
Dandan Bi, Shaochen Yu, Mengjie Zhang, Yuting Huang, Ziyue Dou, Beibei Tian, Jian Lu. The gut virome and regulatory T cell axis in health and systemic disease. Microbiome Research Reports, 2026, 5 (2) : 14 DOI:10.20517/mrr.2026.20

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Chica Cardenas LA,Leonard MM,Baldridge MT,Handley SA. Gut virome dynamics: from commensal to critical player in health and disease Nat Rev Gastroenterol Hepatol. 2025 23 126 44

[2]

Cao Z,Sugimura N,Burgermeister E,Ebert MP,Zuo T,Lan P. The gut virome: a new microbiome component in health and disease eBioMedicine. 2022 81 104113

[3]

Shamash M,Sinha A,Maurice CF. Improving gut virome comparisons using predicted phage host information mSystems. 2025 10 e01364 24

[4]

Gut Virome and Aging: Phage-driven microbial stability and immune modulation. aging dis. 2025

[5]

Lathakumari RH,Vajravelu LK,Gopinathan A.et al. The gut virome and human health: From diversity to personalized medicine Eng Microbiol. 2025 5 100191

[6]

Mahmud MR,Tamanna SK,Akter S.et al. Role of bacteriophages in shaping gut microbial community Gut Microbes. 2024 16 2390720

[7]

Hillary LS,Knotts TA,Adams SH,Ali MR,Olm MR,Emerson JB. DNA extraction and virome processing methods strongly influence recovered human gut viral community characteristics. bioRxiv 2025; bioRxiv:2025.11.25.690293. Available online: https://doi.org/10.1101/2025.11.25.690293. [accessed 18 June 2026]

[8]

Li J,Yang F,Xiao M,Li A. Advances and challenges in cataloging the human gut virome Cell Host Microbe. 2022 30 908 16

[9]

Ugalde V,Contreras F,Prado C,Chovar O,Espinoza A,Pacheco R. Dopaminergic signalling limits suppressive activity and gut homing of regulatory T cells upon intestinal inflammation Mucosal Immunol. 2021 14 652 66

[10]

Hanna BS,Wang G,Galván-Peña S.et al. The gut microbiota promotes distal tissue regeneration via RORγ+ regulatory T cell emissaries Immunity. 2023 56 829 846.e8

[11]

Miranda‐waldetario MCG,Curotto de lafaille MA. Oral tolerance to dietary antigens and Foxp3+ regulatory T cells Immunol Rev. 2024 326 8 16

[12]

Stockdale SR,Shkoporov AN,Khokhlova EV.et al. Interpersonal variability of the human gut virome confounds disease signal detection in IBD Commun Biol. 2023 6 221

[13]

Wu Y,Cheng R,Lin H.et al. Gut virome and its implications in the pathogenesis and therapeutics of inflammatory bowel disease BMC Med. 2025 23 183

[14]

Dagar S,Singh J,Saini A.et al. Gut bacteriome, mycobiome and virome alterations in rheumatoid arthritis Front Endocrinol. 2023 13 1044673

[15]

Tomofuji Y,Kishikawa T,Maeda Y.et al. Whole gut virome analysis of 476 Japanese revealed a link between phage and autoimmune disease Ann Rheum Dis. 2022 81 278 88

[16]

De Jonge PA,Wortelboer K,Scheithauer TPM.et al. Gut virome profiling identifies a widespread bacteriophage family associated with metabolic syndrome Nat Commun. 2022 13 3594

[17]

White Z,Cabrera I,Mei L.et al. Gut inflammation promotes microbiota-specific CD4 T cell-mediated neuroinflammation Nature. 2025 643 509 18

[18]

Barcutean L,Maier S,Burai-patrascu M,Farczadi L,Balasa R. The immunomodulatory potential of short-chain fatty acids in multiple sclerosis Int J Mol Sci. 2024 25 3198

[19]

Larson JH,Jin S,Loschi M.et al. Enforced gut homing of murine regulatory T cells reduces early graft-versus-host disease severity Am J Transplant. 2023 23 1102 15

[20]

Wei X,Zhang X,Cui M,Huang L,Gao D,Hua S. An exploration of the relationship between gut virome and cardiovascular disease: a comprehensive review Rev Cardiovasc Med. 2025 26 36386

[21]

Feng Z,Burgermeister E,Philips A,Zuo T,Wen W. The gut virome in association with the bacteriome in gastrointestinal diseases and beyond: roles, mechanisms, and clinical applications Precis Clin Med. 2025 8 pbaf010

[22]

Liang G,Cobián-Güemes AG,Albenberg L,Bushman F. The gut virome in inflammatory bowel diseases. Curr Opin Virol. 2021;51:190-8

[23]

Chen C,Yan Q,Yao X.et al. Alterations of the gut virome in patients with systemic lupus erythematosus Front. Immunol. 2023 13 1050895

[24]

Guo R,Li S,Zhang Y.et al. Dysbiotic oral and gut viromes in untreated and treated rheumatoid arthritis patients Microbiol Spectr. 2022 10 e00348 22

[25]

Sun Z,Zhou H,Wang Y,Li Z. Regulatory T cells in stroke inflammation: therapeutic perspectives. Neural Regener Res. 2026;21:2178-90

[26]

Yan Q,Huang L,Li S.et al. The Chinese gut virus catalogue reveals gut virome diversity and disease-related viral signatures Genome Med. 2025 17 30

[27]

Nishijima S,Nagata N,Kiguchi Y.et al. Extensive gut virome variation and its associations with host and environmental factors in a population-level cohort Nat Commun. 2022 13 5252

[28]

Zhao X,Cai Y,Hou Y.et al. Commensal viruses promote intestinal stem cell regeneration following radiation damage by inhibiting hyperactivation of RIG‐I and notch signals Adv Sci. 2025 12 e05204

[29]

Leal Rodríguez C,Shah SA,Rasmussen MA.et al. The infant gut virome is associated with preschool asthma risk independently of bacteria Nat Med. 2023 30 138 48

[30]

Zou G,He L,Rao J.et al. Improving the safety and efficacy of phage therapy from the perspective of phage-mammal interactions FEMS Microbiol Rev. 2023 47 fuad042

[31]

Lam S,Bai X,Shkoporov AN.et al. Roles of the gut virome and mycobiome in faecal microbiota transplantation Lancet Gastroenterol Hepatol. 2022 7 472 84

[32]

Dikareva E,Matharu D,Lahtinen E.et al. An extended catalog of integrated prophages in the infant and adult fecal microbiome shows high prevalence of lysogeny Front. Microbiol. 2023 14 1254535

[33]

Xu M,Chen S,Pei H,Hu L,Zhang Y. Engineering bacteriophages for gut health: precision antimicrobials and beyond J Nanobiotechnol. 2026 24 62

[34]

Bao S,Wang H,Li W.et al. Dynamic alterations of the mice gut virome after Coxsackievirus B3 infection J Med Virol. 2022 94 4959 69

[35]

Zhao X,Sun C,Jin M.et al. Enrichment culture but not metagenomic sequencing identified a highly prevalent phage infecting Lactiplantibacillus plantarum in human feces Microbiol Spectr. 2023 11 e04340 22

[36]

Strine MS,Fagerberg E,Darcy PW.et al. Intestinal tuft cell immune privilege enables norovirus persistence Sci. Immunol. 2024 9 eadi7038

[37]

Hou G,Son J,Gomez Castro MF.et al. Innate immune sensing of rotavirus by intestinal epithelial cells leads to diarrhea Cell Host Microbe. 2025 33 408 419.e8

[38]

Harris KG,Morosky SA,Drummond CG.et al. RIP3 regulates autophagy and promotes Coxsackievirus B3 infection of intestinal epithelial cells Cell Host Microbe. 2015 18 221 32

[39]

Makimaa H,Ingle H,Wang L.et al. MDA5-MAVS and interferon-lambda signaling in the intestinal epithelium limit murine astrovirus infection Mucosal Immunol. 2026 19 1749 58

[40]

Janahi EM,Mustafa S,Parkar SFD,Naser HA,Eisa ZM. Detection of enteric viruses and bacterial indicators in a sewage treatment center and shallow water bay Int J Environ Res Public Health. 2020 17 6483

[41]

Kim AH,Armah G,Dennis F.et al. Enteric virome negatively affects seroconversion following oral rotavirus vaccination in a longitudinally sampled cohort of Ghanaian infants Cell Host Microbe. 2022 30 110 123.e5

[42]

Gregory AC,Zablocki O,Zayed AA,Howell A,Bolduc B,Sullivan MB. The gut virome database reveals age-dependent patterns of virome diversity in the human gut Cell Host Microbe. 2020 28 724 740.e8

[43]

Tan SK,Granados AC,Bouquet J.et al. Metagenomic sequencing of stool samples in Bangladeshi infants: virome association with poliovirus shedding after oral poliovirus vaccination Sci Rep. 2020 10 15392

[44]

Truchado P,Garre A,Gil MI,Simón-andreu PJ,Sánchez G,Allende A. Monitoring of human enteric virus and coliphages throughout water reuse system of wastewater treatment plants to irrigation endpoint of leafy greens Sci Total Environ. 2021 782 146837

[45]

Ahmed W,Smith WJ,Tiwari A,Bivins A,Simpson SL. Unveiling indicator, enteric, and respiratory viruses in aircraft lavatory wastewater using adsorption-extraction and Nanotrap® Microbiome A Particles workflows Sci Total Environ. 2023 896 165007

[46]

Toribio-Avedillo D,Blanch AR,Muniesa M,Rodríguez-Rubio L. Bacteriophages as fecal pollution indicators Viruses. 2021 13 1089

[47]

Farkas K,Walker DI,Adriaenssens EM.et al. Viral indicators for tracking domestic wastewater contamination in the aquatic environment Water Res. 2020 181 115926

[48]

Yasui M,Iso H,Torii S,Matsui Y,Katayama H. Applicability of pepper mild mottle virus and cucumber green mottle mosaic virus as process indicators of enteric virus removal by membrane processes at a potable reuse facility Water Res. 2021 206 117735

[49]

Fan S,Xu Z,Liu P,Qin Y,Chen M. Enterovirus 71 2A protease inhibits P-body formation to promote viral RNA synthesis J Virol. 2021 95 e00922 21

[50]

Wang Y,Zou W,Niu Y.et al. Phosphorylation of enteroviral 2Apro at Ser/Thr125 benefits its proteolytic activity and viral pathogenesis J Med Virol. 2022 95 e28400

[51]

Chen L,Hou X,Chu H. The novel role of phage particles in chronic liver diseases Microorganisms. 2023 11 1181

[52]

Ma L,Hung MH,Rashidi Mehrabadi F.et al. Beneficial infections of the enterovirus genus in patients with liver cancer Gut. 2025 74 1667 79

[53]

Adiliaghdam F,Amatullah H,Digumarthi S.et al. Human enteric viruses autonomously shape inflammatory bowel disease phenotype through divergent innate immunomodulation Sci. Immunol. 2022 7 eabn6660

[54]

Zhong Y,Zhang Y,Arcondo JLL.et al. Prophage induction drives soybean rhizobacterial community differentiation and nutrient cycling benefiting root development ISME Communications. 2025 5 ycaf203

[55]

Cortés-Martín A,Denise R,Guerin E.et al. Isolation and characterization of a novel lytic Parabacteroides distasonis bacteriophage φPDS1 from the human gut Gut Microbes. 2024 16 2298254

[56]

Nicolas AM,Sieradzki ET,Pett-Ridge J.et al. A subset of viruses thrives following microbial resuscitation during rewetting of a seasonally dry California grassland soil Nat Commun. 2023 14 5835

[57]

Blanco JCG,Sylla FYD,Granados S,Noghero A,Boukhvalova MS,Kajon AE. Enterovirus D68 infection in cotton rats results in systemic inflammation with detectable viremia associated with extracellular vesicle and neurologic disease Sci Rep. 2025 15 6514

[58]

Hügel A,Weiss C,Ishikawa H.et al. Genotype-dependent cell tropism of EV-A71 at the human blood cerebrospinal fluid and blood brain barrier Microb Pathog. 2026 210 108129

[59]

Khan Mirzaei M,Khan MAA,Ghosh P.et al. Bacteriophages isolated from stunted children can regulate gut bacterial communities in an age-specific manner Cell Host Microbe. 2020 27 199 212.e5

[60]

Xiao Y,Yue X,Zhang X,Yang Y,Zhang Y,Sun L. The role of bacteriophage in inflammatory bowel disease and its therapeutic potential Crit Rev Microbiol. 2025 51 1231 45

[61]

Rothschild-Rodriguez D,Hedges M,Kaplan M,Karav S,Nobrega FL. Phage-encoded carbohydrate-interacting proteins in the human gut Front. Microbiol. 2023 13 1083208

[62]

Lourenço M,Chaffringeon L,Lamy-Besnier Q.et al. The spatial heterogeneity of the gut limits predation and fosters coexistence of bacteria and bacteriophages Cell Host Microbe. 2020 28 390 401.e5

[63]

Eriksen RS,Larsen F,Svenningsen SL,Sneppen K,Mitarai N. The dynamics of phage predation on a microcolony Biophys J. 2024 123 147 56

[64]

Lopez JA,Mckeithen-Mead S,Shi H,Nguyen TH,Huang KC,Good BH. Abundance measurements reveal the balance between lysis and lysogeny in the human gut microbiome. bioRxiv 2024; bioRxiv:2024.09.27.614587. Available online: https://doi.org/10.1101/2024.09.27.614587. [accessed 18 June 2026]

[65]

Lopez JA,Mckeithen-Mead S,Shi H,Nguyen TH,Huang KC,Good BH. Abundance measurements reveal the balance between lysis and lysogeny in the human gut microbiome Curr Biol. 2025 35 2282 2294.e11

[66]

Avellaneda-franco L,Xie L,Nakai M,Barr JJ,Marques FZ. Dietary fiber intake impacts gut bacterial and viral populations in a hypertensive mouse model Gut Microbes. 2024 16 2407047

[67]

Wu D,Zhang C,Liu Y.et al. Beyond faecal microbiota transplantation, the non-negligible role of faecal virome or bacteriophage transplantation J Microbiol Immunol Infect. 2023 56 893 908

[68]

Liu X,Han Z,Ma W.et al. Effects of Lactiplantibacillus plantarum HNU082 intervention on fungi and bacteriophages in different intestinal segments of mice BMC Microbiol. 2025 25 69

[69]

Li Y,Li X,Duan H,Yang K,Ye J. Advances and optimization strategies in bacteriophage therapy for treating inflammatory bowel disease Front Immunol. 2024 15 1398652

[70]

Xing B,Liu C,Chen W.et al. Gut Phage Biobank: a collection of bacteriophages targeting human commensal bacteria Nat Commun. 2025 16 11050

[71]

Naderian R,Alibabaei F,Paraandavaji E,Dehghan P,Eslami M. Phage-microbiota interactions in the gut: implications for health and therapeutic strategies Probiotics Antimicro. Prot. 2025 18 3633 47

[72]

Kurilovich E,Geva-zatorsky N. Effects of bacteriophages on gut microbiome functionality Gut Microbes. 2025 17 2481178

[73]

Kirsch JM,Brzozowski RS,Faith D,Round JL,Secor PR,Duerkop BA. Bacteriophage-bacteria interactions in the gut: from invertebrates to mammals Annu. Rev. Virol. 2021 8 95 113

[74]

Penix T,Favazza J,Rosch JW,Rowe HM. Lipoteichoic acid mediates binding of Streptococcus pneumoniae and influenza A virus mSphere. 2025 10 e00504 25

[75]

Ray RR. Role of virus on oral biofilm: inducer or eradicator? Appl Biochem Biotechnol. 2023;196:1652-68

[76]

Stanifer ML,Karst SM,Boulant S. Regionalization of the antiviral response in the gastrointestinal tract to provide spatially controlled host/pathogen interactions mBio. 2023 e02791 22

[77]

Amatullah H,Jeffrey KL. Epigenome-metabolome-microbiome axis in health and IBD Curr Opin Microbiol. 2020 56 97 108

[78]

Lockhart A,Mucida D,Parsa R. Immunity to enteric viruses Immunity. 2022 55 800 18

[79]

Jaswal K,Todd OA,Behnsen J. Neglected gut microbiome: interactions of the non-bacterial gut microbiota with enteric pathogens Gut Microbes. 2023 15 2226916

[80]

Xu Q,Tang Y,Huang G. Innate immune responses in RNA viral infection Front. Med. 2020 15 333 46

[81]

Enya T,Ross SR. Innate sensing of viral nucleic acids and their use in antiviral vaccine development Vaccines. 2025 13 193

[82]

Beirag N,Varghese PM,Kishore U. Innate immune response to viral infection. In: Kishore U, George AJT, Editors. Innate immunity: pattern recognition and effector mechanisms. Cham: Springer Nature Switzerland; 2025. pp. 199-224

[83]

Boylan BT,Hwang M,Bergmann CC. The impact of innate components on viral pathogenesis in the neurotropic coronavirus encephalomyelitis mouse model Viruses. 2023 15 2400

[84]

Scarpellini E,Fagoonee S,Rinninella E.et al. Gut microbiota and liver interaction through immune system cross-talk: a comprehensive review at the time of the SARS-CoV-2 pandemic JCM. 2020 9 2488

[85]

Li L,Luo J,Zhu Z.et al. SRA suppresses antiviral innate immune response in macrophages by limiting TBK1 K63 ubiquitination via deubiquitinase USP15 Microbiol Spectr. 2022 10 e02028 22

[86]

Li Q,Qin Y,Wang W,Jia M,Zhao W,Zhao C. KAP1-mediated epigenetic suppression in anti-RNA viral responses by direct targeting RIG-I and MDA5 J Immunol. 2021 207 1903 10

[87]

Rivera-Calzada A,Arribas-Bosacoma R,Ruiz-Ramos A.et al. Structural basis for the inactivation of cytosolic DNA sensing by the vaccinia virus Nat Commun. 2022 13 7062

[88]

Chabot E,Durantel D,Lucifora J. TRIM proteins: A ‘swiss army knife’ of antiviral immunity PLoS Pathog. 2025 21 e1013147

[89]

Kalugotla G,Marmerstein V,Baldridge MT. Regulation of host/pathogen interactions in the gastrointestinal tract by type I and III interferons Curr Opin Immunol. 2024 87 102425

[90]

Wan SW,Lee YR,Ho TS,Chang CP. Regulation of innate immune signaling pathways by autophagy in dengue virus infection IUBMB Life. 2021 74 170 9

[91]

Zhou X,Xie F,Wang L.et al. The function and clinical application of extracellular vesicles in innate immune regulation Cell Mol Immunol. 2020 17 323 34

[92]

Raychoudhuri A,Naru AK,Kanubothula SR,Uddala R. Development of an experimental inactivated vaccine from Vero cell adapted Enterovirus D68 Virus Res. 2021 304 198528

[93]

Jin W,Lu J,Zhang X.et al. Efficacy of Coxsackievirus A5 vaccine candidates in an actively immunized mouse model J Virol. 2021 95 e01743 20

[94]

Zhang H,Song Z,Zou J.et al. An infectious clone of enterovirus 71(EV71) that is capable of infecting neonatal immune competent mice without adaptive mutations Emerg Microbes Infect. 2020 9 427 38

[95]

Massimino L,Palmieri O,Facoetti A.et al. Gut virome-colonising Orthohepadnavirus genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation in vivo Gut. 2023 72 1838 47

[96]

Hamade H,Tsuda M,Oshima N.et al. Toll-like receptor 7 protects against intestinal inflammation and restricts the development of colonic tissue-resident memory CD8+ T cells Front. Immunol. 2024 15 1465175

[97]

Wang H,Wang Y,Wu S.et al. STING restricts EV-A71 infection by regulating T Cell development and enhancing immune cell effector function Int J Mol Sci. 2025 26 11441

[98]

Ruohtula T,Kondrashova A,Lehtonen J.et al. ; the DIABIMMUNE Study Group. Immunomodulatory effects of rhinovirus and enterovirus infections during the first year of life Front. Immunol. 2021 11 567046

[99]

Yang X,Shui X,Dai X.et al. PLAC8 promotes EV71 infected inflammatory lesion by disturbing Th-cell-related cytokines release in neonatal mouse Virology. 2021 564 39 45

[100]

Schulte BM,Kramer M,Ansems M.et al. Phagocytosis of enterovirus-infected pancreatic β-cells triggers innate immune responses in human dendritic cells Diabetes. 2010 59 1182 91

[101]

Li L,Huang R,Liu X.et al. Modulation of plasmacytoid dendritic cell and CD4+ T cell differentiation accompanied by upregulation of the cholinergic anti-inflammatory pathway induced by enterovirus 71 Arch Virol. 2024 169 73

[102]

Zhao M,Wang L,Lian G.et al. Characterization of lymphocyte subsets in peripheral blood cells of children with EV71 infection J Microbiol Immunol Infect. 2020 53 705 14

[103]

Aida K,Nishida Y,Tanaka S.et al. RIG-I- and MDA5-initiated innate immunity linked with adaptive immunity accelerates β-cell death in fulminant type 1 diabetes Diabetes. 2011 60 884 9

[104]

Moise L,Gutierrez AH,Bailey-Kellogg C.et al. The two-faced T cell epitope: Examining the host-microbe interface with JanusMatrix Hum Vacc Immunother. 2013 9 1577 86

[105]

Liu W,Moussawi M,Roberts B,Boyson JE,Huber SA. Cross-regulation of T regulatory - cell response after Coxsackievirus B3 infection by NKT and γδ T cells in the mouse Am J Pathol. 2013 183 441 9

[106]

Shi Y,Fukuoka M,Li G.et al. Regulatory T cells protect mice against Coxsackievirus-induced myocarditis through the transforming growth factor β - Coxsackie-Adenovirus receptor pathway Circulation. 2010 121 2624 34

[107]

Andronik A,Lewandowski D,Sulik A,Toczylowski K. The host immune response to enterovirus A71 (EV-A71): from viral immune evasion to immunopathology and prognostic biomarkers of severe disease - a narrative review Viruses. 2025 17 1540

[108]

Li Q,Wang Y,Xue W.et al. Immunomodulatory effects of platelets on the severity of hand, foot, and mouth disease infected with enterovirus 71 Pediatr Res. 2020 89 814 22

[109]

Jansen D,Matthijnssens J. The emerging role of the gut virome in health and inflammatory bowel disease: challenges, covariates and a viral imbalance Viruses. 2023 15 173

[110]

Cao Z,Fan D,Sun Y.et al. The gut ileal mucosal virome is disturbed in patients with Crohn’s disease and exacerbates intestinal inflammation in mice Nat Commun. 2024 15 1638

[111]

Tian X,Li S,Wang C.et al. Gut virome-wide association analysis identifies cross-population viral signatures for inflammatory bowel disease Microbiome. 2024 12 130

[112]

Vásquez J,Doncel P,Camacho J,Ruiz E,Recio V,Tarragó D. Targeted virome deep sequencing reveals frequent herpesvirus detection in intestinal biopsies of inflammatory bowel disease patients PLoS ONE. 2025 20 e0337322

[113]

Yan A,Butcher J,Schramm L,Mack DR,Stintzi A. Multiomic spatial analysis reveals a distinct mucosa-associated virome Gut Microbes. 2023 15 2177488

[114]

Yan A,Butcher J,Mack DR,Stintzi A. The colonic mucosal virome in inflammatory bowel disease reveals Crassvirales depletion and disease-specific virome features Gut Microbes. 2025 17 2539450

[115]

Yang F,Xiong L,Li M.et al. A signature-protein-based approach for accurate and efficient profiling of the human gut virome Cell Rep Methods. 2026 6 101250

[116]

Sinha A,Li Y,Mirzaei MK.et al. Transplantation of bacteriophages from ulcerative colitis patients shifts the gut bacteriome and exacerbates the severity of DSS colitis Microbiome. 2022 10 105

[117]

Coffey MJ,Low I,Stelzer-Braid S.et al. The intestinal virome in children with cystic fibrosis differs from healthy controls PLoS ONE. 2020 15 e0233557

[118]

Singh G,Ansari S,Yadav S,Aran KR. Gut microbiota’s role in NAFLD- and HBV/HCV-related hepatocellular carcinoma: Mechanisms and therapeutic implications Microb Pathog. 2026 211 108273

[119]

Liu L,Liang L,Liang H.et al. Microbiome-metabolome generated bile acids gatekeep infliximab efficacy in Crohn’s disease by licensing M1 suppression and Treg dominance J Adv Res. 2026 83 789 806

[120]

Rashed R,Valcheva R,Dieleman LA. Manipulation of gut microbiota as a key target for Crohn’s disease Front. Med. 2022 9 887044

[121]

Jin J,Yao G,Zhang X.et al. Gut virome dysbiosis contributes to premature ovarian insufficiency by modulating gut bacteriome Gut Microbes. 2026 18 2611645

[122]

Zhang J,Zhang Y,Xia Y,Sun J. Imbalance of the intestinal virome and altered viral-bacterial interactions caused by a conditional deletion of the vitamin D receptor Gut Microbes. 2021 13 1957408

[123]

Poma AM,Hammerstad SS,Genoni A,Basolo A,Dahl-Jorgensen K,Toniolo A. Immune transcriptome of cells infected with enterovirus strains obtained from cases of autoimmune thyroid disease Microorganisms. 2021 9 876

[124]

Sioofy-khojine A,Richardson SJ,Locke JM.et al. Detection of enterovirus RNA in peripheral blood mononuclear cells correlates with the presence of the predisposing allele of the type 1 diabetes risk gene IFIH1 and with disease stage Diabetologia. 2022 65 1701 9

[125]

Richardson SJ,Rodriguez-Calvo T,Laiho JE.et al. ; for the nPOD-Virus Group. Joint analysis of the nPOD-Virus Group data: the association of enterovirus with type 1 diabetes is supported by multiple markers of infection in pancreas tissue Diabetologia. 2025 68 1226 41

[126]

Mønsted MØ, Pedersen K, Jensen MH, et al. Genetic and transcriptional dysregulation of innate antiviral immune pathways in type 1 diabetes Immunol Lett. 2025 276 107060

[127]

Tekin B,Boire N,Shah K,Hanson J,Bridges AG. Viral panniculitis in a patient with disseminated opportunistic Enterovirus infection J Cutan Pathol. 2020 48 434 8

[128]

Jayaraman S,Tiniakou E,Morgenlander WR,Na M,Christopher‐Stine L,Larman HB. Comprehensive enteroviral serology links infection and anti-melanoma differentiation-associated protein 5 dermatomyositis ACR Open Rheumatol. 2024 7 e11752

[129]

Real-Fernández F,Gallo A,Nuti F.et al. ELISA based on peptide antigens reproducing cross-reactive viral epitopes to detect antibodies in latent autoimmune diabetes in adults vs. type 1 diabetes MethodsX. 2021 8 101452

[130]

Garg I,Meyer BI,Gallo RA,Wester ST,Pelaez D. A novel association between human papillomavirus and thyroid eye disease. medRxiv 2024; medRxiv:2024.04.27.24306443. Available online: https://doi.org/10.1101/2024.04.27.24306443. [accessed 18 June 2026]

[131]

Morse ZJ,Simister RL,Crowe SA,Horwitz MS,Osborne LC. Virus induced dysbiosis promotes type 1 diabetes onset Front Immunol. 2023 14 1096323

[132]

Veronese-Paniagua DA,Millman JR. The perfect storm: unraveling the interplay of genetic predisposition and viral triggers in type 1 diabetes pathogenesis Front Endocrinol. 2025 16 1734431

[133]

Yang C,Sun F,Wang F.et al. The interferon regulatory factors, a double-edged sword, in the pathogenesis of type 1 diabetes Cell Immunol. 2022 379 104590

[134]

Butrym M,Byvald F,Blanter M.et al. Vemurafenib inhibits the replication of diabetogenic enteroviruses in intestinal epithelial and pancreatic beta cells Antiviral Res. 2024 231 106021

[135]

Stögbauer J,Schegerer V,Berger FK.et al. Severe coxsackie virus B5 encephalitis mimics autoimmune limbic encephalitis in a young woman under long-term B-cell depletion with ocrelizumab: a case report Mult Scler. 2025 31 1258 61

[136]

You S,Wang L,Tsai H,Teresa Teng Y,Chen S,Wang S. Therapeutic determinants of melatonin in hepatitis caused by Coxsackievirus B3 infection Antiviral Res. 2025 239 106191

[137]

Kimura T,Flynn CT,Whitton JL. Hepatocytes trap and silence coxsackieviruses, protecting against systemic disease in mice Commun Biol. 2020 3 580

[138]

Park J,Shin H,Rhyu H,Kim S,Jeon E,Lim B. Vascular endothelial integrity affects the severity of enterovirus-mediated cardiomyopathy Int J Mol Sci. 2021 22 3053

[139]

Hsueh T,Lin W,Dalley JW,Tsai T. The pharmacological effects and pharmacokinetics of active compounds of artemisia capillaris Biomedicines. 2021 9 1412

[140]

Bharathwajchetty B,Kumar A,Deevi P.et al. Gut microbiota and their influence in brain cancer milieu J Neuroinflammation. 2025 22 129

[141]

Guerin E,Hill C. Shining light on human gut bacteriophages Front Cell Infect Microbiol. 2020 10 481

[142]

Da Silva AF,Wallau GL. Bioinformatic identification of viral genomes from high-throughput metagenomic sequencing data. In: Muley VY, Editors. Computational virology. New York, NY: Springer US; 2025. pp. 1-22

[143]

Casey E,Mcdonnell B,White K.et al. Needle in a Whey-Stack: PhRACS as a discovery tool for unknown phage-host combinations mBio. 2022 13 e03334 21

[144]

Schmitz D,Zwagemaker F,Nooij S.et al. Accessible viral metagenomics for public health and clinical domains with Jovian Sci Rep. 2024 14 26018

[145]

Farfán J,Gonzalez JM,Vives M. The immunomodulatory potential of phage therapy to treat acne: a review on bacterial lysis and immunomodulation PeerJ. 2022 10 e13553

[146]

Suda T,Hanawa T,Tanaka M.et al. Modification of the immune response by bacteriophages alters methicillin-resistant Staphylococcus aureus infection Sci Rep. 2022 12 15656

[147]

Su J,Wu Y,Wang Z.et al. Probiotic biofilm modified scaffolds for facilitating osteomyelitis treatment through sustained release of bacteriophage and regulated macrophage polarization Materials Today Bio. 2025 30 101444

[148]

Islam MS,Wei P,Zhang K,Nime I,Pan F. Phage therapy modulates the gut microbiome and immune responses in non-typhoidal Salmonella-induced colitis Food Res Int. 2025 219 117003

[149]

Cheng F,Soleimani Samarkhazan H,Khazaei Y. CRISPR-engineered microbiome: living therapeutics revolutionize blood cancer immunotherapy npj Biofilms Microbiomes. 2025 12 17

[150]

Getz LJ,Patel PH,Maxwell KL. A solution to the postantibiotic era: phages as precision medicine Curr Opin Microbiol. 2025 86 102613

[151]

Liu J,Lu X,Zhou W. Elevated circulating miR-494 in plasma of children with enterovirus 71 induced hand, foot, and mouth disease and its potential diagnostic value Acta Virol. 2020 64 338 43

[152]

Morichi S,Suzuki S,Nishimata S,Yamanaka G,Kashiwagi Y,Kawashima H. Increased platelet-derived growth factor and cytokine levels in the cerebrospinal fluid of patients of sudden unexpected death with or without viral infection Indian J Pediatr. 2021 88 879 84

[153]

Lei L,Li Q,Xu S.et al. Transplantation of enterovirus 71 virion protein particle vaccine protects against enterovirus 71 infection in a neonatal mouse model Ann Transplant. 2021 26 924461

[154]

Chin CL,Lin YL,Cheng PY,Lee P,Chiang BL. Effective mucosal adjuvantation of the intranasal enterovirus A71 vaccine with zymosan Immunology. 2025 174 349 62

[155]

Swain SK,Panda S,Sahu BP,Sarangi R. Activation of host cellular signaling and mechanism of enterovirus 71 viral proteins associated with hand, foot and mouth disease Viruses. 2022 14 2190

[156]

Shimizu H. Inactivated enterovirus A71 vaccines and moving forward Lancet Reg Health West Pac. 2021 16 100292

[157]

Ye L,Chen J,Fang T.et al. Vaccination coverage estimates and utilization patterns of inactivated enterovirus 71 vaccine post vaccine introduction in Ningbo, China BMC Public Health. 2021 21 1118

[158]

Jiang H,Zhang Z,Rao Q.et al. The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming, China Emerg Microbes Infect. 2021 10 619 28

[159]

Duan X,Zhang L,Ding L.et al. Effectiveness of enterovirus A71 vaccine against pediatric HFMD and disease profile of post-vaccination infection Vaccine. 2024 42 2317 25

[160]

Zhang P,Zou W,Xiong R,Wu Y,Fan C,Peng Y. Enterovirus A71 2A‐S125A acts as an attenuated vaccine candidate, indicating a universal approach in developing enterovirus vaccines J Med Virol. 2024 96 e29838

[161]

Zimina A,Kouiavskaia D,Viktorova EG.et al. Viral vector-driven trans-encapsidation of replicon RNAs as a rapid approach for the development of safe and economically attractive anti-enterovirus vaccines. bioRxiv 2025; bioRxiv:2025.12.01.691592. Available online: https://doi.org/10.1101/2025.12.01.691592. [accessed 18 June 2026]

[162]

Cinti L,Spezia PG,Roberto P.et al. Assessment of Torquetenominivirus (TTMV) and Torquetenomidivirus (TTMDV) as Complementary Biomarkers to Torquetenovirus (TTV) Int J Mol Sci. 2025 26 1022

[163]

Camargo AP,Nayfach S,Chen IA.et al. IMG/VR v4: an expanded database of uncultivated virus genomes within a framework of extensive functional, taxonomic, and ecological metadata Nucleic Acids Res. 2023 51 D733 43

[164]

Mihara T,Nishimura Y,Shimizu Y.et al. Linking virus genomes with host taxonomy Viruses. 2016 8 66

PDF

0

Accesses

0

Citation

Detail

Sections
Recommended

/